-
A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer - Beyond the Abstract
04 Jan 2024 06:16 GMT
… leuprolide acetate or degarelix at baseline were transitioned … unrelated to the study treatment. The most frequently … roles with Dendreon, Myriad Pharmaceuticals, and Pfizer/Astellas … Pharma Switzerland GmbH. Medical writing and editorial assistance …
-
Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review
13 Nov 2023 04:33 GMT
… availability, comorbidities, and drug–drug interactions. For patients … its FDA approval. Additionally, the TheraP trial demonstrated … already in clinical trials. These include … Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment …
-
Summary of opinion: Degarelix Accord,degarelix acetate, 20/07/2023, Positive
22 Jul 2023 00:00 GMT
… authorisation for the medicinal product Degarelix Accord, intended for the treatment of hormone … :
Degarelix Accord is a gonadotrophin releasing hormone (GnRH) antagonist indicated:
for treatment …
-
Summary of opinion: Degarelix Accord,degarelix acetate, 20/07/2023, Positive
21 Jul 2023 12:20 GMT
… authorisation for the medicinal product Degarelix Accord, intended for the treatment of hormone … :
Degarelix Accord is a gonadotrophin releasing hormone (GnRH) antagonist indicated:
for treatment …
-
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 July 2023, CHMP, 21/07/2023
17 Jul 2023 15:08 GMT
… for Degarelix Accord (degarelix acetate), a generic medicine for the treatment of … tocilizumab), a biosimilar medicine intended for the treatment of rheumatoid arthritis, … Yesafili (aflibercept), a biosimilar treatment of age-related macular degeneration …
-
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 July 2023
17 Jul 2023 15:08 GMT
… for Degarelix Accord (degarelix acetate), a generic medicine for the treatment of … tocilizumab), a biosimilar medicine intended for the treatment of rheumatoid arthritis, … Yesafili (aflibercept), a biosimilar treatment of age-related macular degeneration …
-
Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Prostatic Neoplasms, Date of authorisation: 29/09/2023, Status: Authorised
17 Jul 2023 13:43 GMT
… that it responds to treatments that reduce the levels … active substance degarelix and is a ‘generic medicine’. This means … that Degarelix Accord contains the … the EU. The reference medicine for Degarelix Accord is Firmagon. …
-
Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Prostatic Neoplasms, Date of authorisation: 29/09/2023, Status: Authorised
17 Jul 2023 13:43 GMT
… that it responds to treatments that reduce the levels … active substance degarelix and is a ‘generic medicine’. This means … that Degarelix Accord contains the … the EU. The reference medicine for Degarelix Accord is Firmagon. …
-
Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
11 Mar 2024 10:19 GMT
… randomized clinical trials (a phase 2 trial of relugolix vs degarelix, and a … subset of the phase 3 HERO trial of … (320-mg loading dose) or degarelix, 80 mg, 4-week depot … of these 2 randomized clinical trials suggest that relugolix rapidly …
-
FDA gives Ferring go-ahead for Adstiladrin gene therapy manufacturing
14 Jun 2023 06:06 GMT
… and Drug Administration (FDA) approved Ferring Pharmaceuticals’ Prior … Pharmaceuticals has a clinical development pipeline consisting of therapies for reproductive medicine … , including Firmagon (degarelix), Minirin (desmopressin … . Common treatment options for …